Newsletter No. 92 -- April 2007
BIOENGINEERING RESEARCH PARTNERSHIPS (BRP)(Multiple IC's)(R01) (PAR-07-352)
Application Submission/Receipt Date(s): Standard dates apply
Participating Institutes and Centers (ICs) of the NIH invite applications for R01 awards to support Bioengineering Research Partnerships (BRPs) for basic, applied, and translational multi-disciplinary research that addresses important biological or medical research problems. In the context of this program, a partnership is a multi-disciplinary research team that applies an integrative, systems approach to develop knowledge and/or methods to prevent, detect, diagnose, or treat disease or to understand health and behavior.
AVON-NCI "PROGRESS FOR PATIENTS" (PFP) AWARDS FOR EARLY PHASE CLINICAL INTERVENTIONS AND BIOMARKERS IN BREAST CANCER (LIMITED COMPETITIVE SUPPLEMENTS [REVISIONS] FOR P30 CANCER CENTER SUPPORT GRANTS) (NCI, AVON FOUNDATION AND FNIH) (PAR-07-244)
AVON-NCI "PROGRESS FOR PATIENTS" (PFP) AWARDS FOR EARLY PHASE CLINICAL INTERVENTIONS AND BIOMARKERS IN BREAST CANCER (LIMITED COMPETITIVE SUPPLEMENTS [REVISIONS] FOR P50 SPORE GRANTS) (NCI, AVON FOUNDATION AND FNIH) (PAR-07-245)
Application Receipt/Submission Date(s): April 27, 2007; November 15, 2007
The awards are designed to support activities that could not have been anticipated until recently, thus minimizing delays in conducting novel and promising Phase I and II clinical trials and studies focusing on risk assessment or validation of biomarkers in human subjects. All NCI-designated Cancer Center investigators are eligible to apply, so long as the criteria in regard to project responsiveness are met. However, anticipated funding period of the Avon-NCI award should not extend beyond the end date of the 5-year parent P30 project period or the project period of subcontractor grants.
URL (for P30 grants): http://grants.nih.gov/grants/guide/pa-files/PAR-07-244.html
URL (for P50 grants): http://grants.nih.gov/grants/guide/pa-files/PAR-07-245.html
INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARD (U54) (ROADMAP)(RFA-RM-07-007)
Application Receipt Date: October 24, 2008
The goal of the Institutional Clinical and Translational Science Award (CTSA) program is to transform the local, regional and national environment for clinical and translational science, thereby increasing the efficiency and speed of clinical and translational research. This transformation will be achieved by creating an academic home, which can be a center, department, or Institute (C/D/I), comprising faculty and programs that integrate clinical and translational science across multiple departments, schools, clinical and research institutes and hospitals. The C/D/I should provide clinical research resources including infrastructure and training to various disciplines in its institution (e.g., medicine, dentistry, nursing, pharmacy, public health, biostatistics, epidemiology, bioengineering) for the benefit of researchers, trainees, and research projects across multiple aspects of health promotion and disease prevention, pre-emption, and treatment studied by a wide range of NIH Institutes and Centers.
DEVELOPMENT OF ASSAYS FOR HIGH-THROUGHPUT DRUG SCREENING (NIDDK, NCI, NIAID, NIMH) (R01) (PA-07-320)
Receipt/Submission Date(s): Multiple dates, see announcement.
The goal of this FOA is to establish a stream of scientifically and technologically outstanding assays that can be automated for HTS at an NIH-funded (or other) facility.
NCI: The NCI is especially interested in proposals related to cancer prevention, treatment or response to treatment using imaging agents, molecular markers, or biochemical pathways. Assays pertinent to the mission of NCI should be justified as relevant to cancer and may include any physiology, cell biology or developmental process with the goal of identifying molecules that either perturb the system (e.g., drugs for cancer prevention or treatment) or yield molecular information (e.g., imaging agents).
INNOVATIONS IN BIOMEDICAL COMPUTATIONAL SCIENCE AND TECHNOLOGY (MULTIPLE ICS)(R01) (PAR-07-344)
Application Receipt/Submission Date(s): May 24, 2007; September 24, 2007; January 24, 2008; May 24, 2008; September 24, 2008, January 24, 2009
The NIH is interested in promoting research and developments in computational science and technology that will support rapid progress in areas of scientific opportunity in biomedical research. The Institutes and Centers of the NIH offer support through the current solicitation for fundamental research in biomedical information science and technology as well as for the development of new informatics, computational and mathematical tools and technologies.
NIST ADVANCED TECHNOLOGY PROGRAM (ATP)(2007-ATP-01)
Proposal receipt date: May 21, 2007
NIST is soliciting proposals in all technology areas (Competition Number 2007-A) as well as four broad Crosscutting Areas of National Interest. Four broad Crosscutting Areas of National Interest for the 2007 Competition provide a framework that links a diversity of technical areas to broad-based economic and societal benefits that are important for technological competitiveness and are well-known priorities for the nation. The areas of interest are each multi-disciplinary technological areas that impact a multitude of industry sectors and applications, and represent technology frontiers with many high-technical risk challenges. They also represent areas where teaming among industry, universities, government labs, and regional centers of excellence is likely to be highly competitive due to the nature of the technical challenges and the potential for economic benefits. The four areas are:
CONTINUATION OF THE EXTENSION OF THE NIH PILOT STUDY TO SHORTEN THE REVIEW CYCLE FOR NEW INVESTIGATOR R01 APPLICATIONS (NOT-OD-07-058)
The pilot effort was begun in 2006, and extended in January 2007, to allow new investigators to have the option of rapidly submitting a resubmission/amended R01 application for consecutive review cycles, saving four months. The Center for Scientific Review is committed to continuing this pilot for the current study sections and to the extension to all new investigator R01 applications by the end of 2007. Forty-six study sections will be included for the May/June 2007 meetings.
NEW AND IMPROVED NIH "WELCOME WAGON" LETTER.
The NIH "Welcome Wagon" letter is sent to new NIH grantees and highlights key policy requirements and important grant information. However, it can also be a great resource for anyone new to the NIH grants process. The Office of Policy for Extramural Research has recently updated the letter, which is available at the following Web sites: Policy Sources page, Grants Management Advisory Committee sub-page and the public OER Grants Policy Web page. A table of contents that visitors may enable or disable has been added for quick navigation to sections of the document. It's a great resource for NIH grants management staff who receive calls from potential applicants looking for resource documents and helpful Web sites, so check it out and bookmark it in your Web browser for future reference.
ACMUI SEEKS NUCLEAR PHARMACIST
The U.S. Nuclear Regulatory Commission is advertising for nominations for the position of nuclear pharmacist on the Advisory Committee on the Medical Uses of Isotopes. Nominations are due on or before May 29, 2007.
GUEST AUTHOR OPPORTUNITIES IN THE NIH MICAD DATABASE
The Molecular Imaging and Contrast Agent Database (MICAD) program has been developed as a key component of the NIH Molecular Imaging Roadmap to provide freely accessible online scientific information on in vivo molecular imaging and contrast agents. To accelerate expansion of the database to include all published agents, the MICAD program has implemented a procedure for members of the imaging community to write and submit entries (chapters) as guest authors to the database. All members of the imaging community are encouraged to consider this guest author opportunities. For further information, please contact the MICAD staff at email@example.com. Individual guest authors will be provide with detailed instructions, style guidelines, and a chapter template. The name of the contributing author(s) will be acknowledged and included in the MICAD online publication.
RSNA CLINICAL TRIALS METHODOLOGY WORKSHOP, JANUARY 5-11, 2008, PHOENIX, AZ
Application deadline: June 5, 2007
This intensive 6 ½ workshop is intended for faculty members, fellows, and 4th year residents in radiology, nuclear medicine, and radiation oncology departments, with MD or PhD degrees. Applicants will be competitively selected.
17th International Symposium on Radiopharmaceutical Sciences
April 30 - May 4, 2007, Aachen, Germany
International Symposium on Ultrasonic Imaging and Tissue Characterization
May 16-18, 2007, Holiday Inn/Rosslyn Westpark Hotel, Arlington, Virginia
ISMRM 15th Scientific Meeting and Exhibition
May 19 - 25, 2007, Berlin, Germany
Society of Nuclear Medicine 54th Annual Scientific Meeting
June 2 - 6, 2007, Washington, DC
Society for Imaging Informatics in Medicine (SIIM)
June 7-10, 2007, Providence, RI
Frontiers of Biomedical Imaging Science
June 27-29 2007, Nashville, Tennessee
CARS 2007 Computer Assisted Radiology and Surgery -21st International Congress and Exhibition
June 27 - 30, 2007, Bonn, Germany
American Association of Physicists in Medicine (AAPM) - 49th Annual Meeting
July 22-26, 2007, Minneapolis, MN
Molecular Imaging Joint Conference of the Academy of Molecular Imaging and the Society for Molecular Imaging
September 7 - 11, 2007, Providence, Rhode Island
If you wish to remain on the list, no action is necessary. If you wish to be added to the list, please contact Dr Barbara Croft by return e-mail (firstname.lastname@example.org). Please include your complete mailing address, title, phone and fax numbers. Cancer Imaging Program, Division of Cancer Treatment and Diagnosis, NCI 6130 Executive Boulevard - MSC-7412 Bethesda, MD 20892-7412 Tel: 301 496 9531 Fax: 301 480 3507